Drug:
Reaction: DRUG DOSE OMISSION BY DEVICE
20260101 - 20261231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 26482182 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Device issue, Device defective, Product tampering, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 302 | 26482187 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 303 | 26482188 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 304 | 26482194 |
US |
||
Drug dose omission by device, Device delivery system issue, Wrong technique in device usage process, Device issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 305 | 26482195 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 306 | 26482196 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, LEVOCETIRIZINE DIHYDROCHLORIDE, LORATADINE, LORATADINE TABLET, |
||||
| 307 | 26482197 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 308 | 26482199 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 309 | 26482200 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Wrong technique in device usage process, Device delivery system issue, Device issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 310 | 26482201 |
US |
||
Drug dose omission by device, Device defective, Product use in unapproved indication, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, |
||||
| 311 | 26482202 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device occlusion, Device issue, Device delivery system issue, Product tampering, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 312 | 26482203 |
US |
||
Taste disorder, Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, Product taste abnormal, Device defective, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, NASAL, SODIUM CHLORIDE, SALINE, |
||||
| 313 | 26482204 |
US |
||
Drug effective for unapproved indication, Drug dose omission by device, Device defective, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 314 | 26482232 |
US |
||
Drug dose omission by device, Wrong technique in device usage process, Device delivery system issue, Device occlusion, Product physical issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 315 | 26482236 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Wrong technique in device usage process, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 316 | 26482239 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Device malfunction, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 317 | 26482242 |
US |
||
Drug dose omission by device, Device delivery system issue, Wrong technique in device usage process, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 318 | 26482271 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, Device issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 319 | 26482272 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Wrong technique in device usage process, Device delivery system issue, Device issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 320 | 26482279 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Wrong technique in product usage process, Product use issue, Device delivery system issue, Device issue, Device occlusion, Product physical issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 321 | 26482295 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device occlusion, Wrong technique in product usage process, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 322 | 26482297 |
US |
||
Product use in unapproved indication, Wrong technique in product usage process, Drug dose omission by device, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 323 | 26482299 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Device delivery system issue, Wrong technique in device usage process, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 324 | 26482301 |
US |
||
Drug dose omission by device, Device delivery system issue, Product use in unapproved indication, Product use issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 325 | 26482309 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Wrong technique in device usage process, Device delivery system issue, Device issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 326 | 26482311 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Wrong technique in device usage process, Device delivery system issue, Device defective, Product label issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 327 | 26482314 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Product use issue, Wrong technique in device usage process, Device occlusion, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 328 | 26482321 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Product use issue, Wrong technique in device usage process, Wrong technique in product usage process, Device defective, Device delivery system issue, Device issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, ADALIMUMAB, |
||||
| 329 | 26482323 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Device issue, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 330 | 26482327 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 331 | 26482330 |
US |
||
Drug dose omission by device, Product use issue, Device delivery system issue, Device defective, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 332 | 26482331 |
US |
||
Drug dose omission by device, Device delivery system issue, Device breakage, Drug effective for unapproved indication, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 333 | 26482408 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, Device defective, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 334 | 26482414 |
US |
||
Drug dose omission by device, Device delivery system issue, Product use issue, Device issue, Device occlusion, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 335 | 26482423 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, Device occlusion, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 336 | 26482425 |
US |
||
Drug dose omission by device, Device delivery system issue, Device occlusion, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 337 | 26482426 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Device delivery system issue, Device occlusion, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 338 | 26482429 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Wrong technique in device usage process, Product tampering, Device delivery system issue, Device occlusion, Device malfunction, Circumstance or information capable of leading to medication error, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 339 | 26482433 |
US |
||
Device issue, Drug dose omission by device, Product use in unapproved indication, Device delivery system issue, Product tampering, Product communication issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, |
||||
| 340 | 26482434 |
US |
||
Drug dose omission by device, Device delivery system issue, Wrong technique in device usage process, Product use issue, Device issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 341 | 26482442 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, Device occlusion, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 342 | 26482443 |
US |
||
Drug dose omission by device, Device delivery system issue, Device occlusion, Product deposit, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 343 | 26482444 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 344 | 26482447 |
US |
||
Drug dose omission by device, Product use issue, Device delivery system issue, Device failure, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 345 | 26482523 |
US |
||
Drug dose omission by device, Device issue, Product use in unapproved indication, Product use issue, Device occlusion, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 346 | 26482526 |
US |
||
Drug dose omission by device, Device issue, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 347 | 26482530 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Device delivery system issue, Device issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 348 | 26482546 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Device issue, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 349 | 26482547 |
US |
||
Product use issue, Drug dose omission by device, Drug effective for unapproved indication, Device issue, Device delivery system issue, Wrong technique in device usage process, Product tampering, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, MONTELUKAST SODIUM, |
||||
| 350 | 26482548 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Device delivery system issue, Device issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 351 | 26482549 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 352 | 26482553 |
US |
||
Drug dose omission by device, Product use issue, Device occlusion, Wrong technique in device usage process, Device issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, IPRATROPIUM BROMIDE, CETIRIZINE HYDROCHLORIDE, |
||||
| 353 | 26482561 |
US |
||
Product use issue, Product use in unapproved indication, Drug dose omission by device, Device issue, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 354 | 26482566 |
US |
||
Product use in unapproved indication, Product use issue, Drug dose omission by device, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 355 | 26482567 |
US |
||
Drug dose omission by device, Device delivery system issue, Device occlusion, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 356 | 26482579 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, Device issue, Wrong technique in device usage process, Device occlusion, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 357 | 26482588 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 358 | 26482590 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, Wrong technique in device usage process, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 359 | 26482593 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, Device issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 360 | 26482595 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, Device defective, Device breakage, Device occlusion, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 361 | 26482597 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Device delivery system issue, Wrong technique in device usage process, Product use issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 362 | 26482598 |
US |
||
Product use in unapproved indication, Product use issue, Wrong technique in device usage process, Drug dose omission by device, Device delivery system issue, Device issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 363 | 26482602 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 364 | 26482603 |
US |
||
Hypersensitivity, Drug dose omission by device, Product use in unapproved indication, Product use issue, Device mechanical issue, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 365 | 26482604 |
US |
||
Product use in unapproved indication, Wrong technique in device usage process, Product use issue, Drug dose omission by device, Device delivery system issue, Product label issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 366 | 26482605 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 367 | 26482606 |
US |
||
Drug dose omission by device, Device issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 368 | 26482616 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 369 | 26482619 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Device difficult to use, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 370 | 26482637 |
US |
2 | |
Device issue, Drug dose omission by device, |
||||
GUSELKUMAB, |
||||
| 371 | 26482650 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 372 | 26482667 |
US |
||
Somnolence, Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, Wrong technique in device usage process, Wrong technique in product usage process, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 373 | 26482670 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Product use issue, Device delivery system issue, Product tampering, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 374 | 26482671 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Product use issue, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 375 | 26482677 |
US |
||
Drug dose omission by device, Product use issue, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, FENOFIBRATE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, |
||||
| 376 | 26482681 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Product use issue, Device delivery system issue, Wrong technique in device usage process, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 377 | 26482682 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, Device issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 378 | 26482687 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device breakage, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 379 | 26482692 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, Device issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 380 | 26482697 |
US |
||
Cough, Hypersensitivity, Insomnia, Sneezing, Drug dose omission by device, Product use in unapproved indication, Device delivery system issue, Product tampering, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 381 | 26482698 |
US |
||
Product use in unapproved indication, Product use issue, Drug dose omission by device, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 382 | 26482713 |
US |
||
Nasal dryness, Therapy interrupted, Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 383 | 26482714 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 384 | 26482717 |
US |
||
Insomnia, Drug dose omission by device, Device delivery system issue, Device defective, Drug ineffective for unapproved indication, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 385 | 26482719 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, Device malfunction, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, VARENICLINE, |
||||
| 386 | 26482720 |
US |
||
Drug dose omission by device, Drug effective for unapproved indication, Device occlusion, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 387 | 26482769 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 388 | 26482770 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, Product tampering, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 389 | 26482771 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, LORATADINE, LORATADINE TABLET, |
||||
| 390 | 26482774 |
US |
||
Product use in unapproved indication, Drug dose omission by device, Device delivery system issue, Device occlusion, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, CETIRIZINE HYDROCHLORIDE, |
||||
| 391 | 26482780 |
US |
||
Drug dose omission by device, Product use in unapproved indication, Product use issue, Device delivery system issue, Device defective, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 392 | 26482786 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 393 | 26482790 |
US |
||
Product use in unapproved indication, Device delivery system issue, Drug dose omission by device, Wrong technique in device usage process, Device occlusion, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 394 | 26482793 |
US |
||
Product use in unapproved indication, Device delivery system issue, Drug dose omission by device, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 395 | 26482800 |
US |
||
Aphonia, Device delivery system issue, Drug dose omission by device, Product use in unapproved indication, Product use issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 396 | 26482802 |
US |
||
Drug dose omission by device, Device delivery system issue, Product tampering, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 397 | 26482803 |
US |
||
Malaise, Drug dose omission by device, Product use issue, Device delivery system issue, Drug effective for unapproved indication, Device occlusion, Device issue, Product tampering, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, FAMOTIDINE, ASCORBIC ACID, ERGOCALCIFEROL, MAGNESIUM, |
||||
| 398 | 26482804 |
US |
||
Drug dose omission by device, Device delivery system issue, Device issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 399 | 26482808 |
US |
||
Drug dose omission by device, Incorrect dose administered by device, Device delivery system issue, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 400 | 26482809 |
US |
||
Product use issue, Recalled product administered, Drug dose omission by device, Device occlusion, Device delivery system issue, Device issue, Device defective, |
||||
OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28